Herpes Simplex Virus Type 1 DNA in Human Brain Tissue

Any Association with Mental Disease?
  • J. Rajčáni
  • M. Murányiová
  • M. Kúdelová
  • J. Pogády
  • V. Mucha
  • P. Babál


The putative role of viruses, especially of herpes simplex virus (HSV), in the etiology of schizophrenia and related mental disorders has been discussed since the finding of elevated antibody levels to HSV type 1 in psychiatric patients (Rimón and Halonen, 1969). Líbiková (1983) found that the geometric mean titer of neutralizing antibodies (NA) to HSV type 1 was higher in each age group of schizophrenic (SCH) patients as compared to controls. The hemagglutination inhibition antibodies to measles virus and the complement fixation antibodies to varicella—zoster virus were not increased when tested in the same sera. Repeated serologic investigation with a great number of sera from SCH patients and controls confirmed the elevated NA titers in the presence and absence of complement in the sera of domestic SCH patients but not in those obtained from abroad (Rajčáni et al., 1987). Using ELISA and a sensitive neutralization test in the presence of complement, we found that both tests were positive in 42 of 262 (16%) CSF samples from SCH patients. The NA titered ≥ 4 and the ELISA ≥ 128 (Bártová et al., 1987). For this reason we decided to compare the results of both tests in a further representative group of SCH patients.


Herpes Simplex Virus Herpes Simplex Type Neutralize Antibody Trigeminal Ganglion Herpes Simplex Virus Infection 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albrecht, P., Torrey, E. F., Boone, E., and Hicks, J. T., 1980, Raised cytomegalovirus antibody level in cerebrospinal fluid of schizophrenic patients, Lancet 2: 769–772.PubMedCrossRefGoogle Scholar
  2. Baringer, J. R., 1975, Herpes simplex virus infection of nervous tissue in animals and man, Prog. Med. Virol. 20: 1–16.PubMedGoogle Scholar
  3. Baringer, J. R., and Swoveland, P., 1973, Recovery of herpes simplex virus from human trigeminal ganglions, N. Engl. J. Med. 288: 648–650.PubMedCrossRefGoogle Scholar
  4. Baartov, L, Rajìni, J., and Pogrady, J., 1987, Herpes simplex virus antibodies in the cerebrospinal fluid of schizophrenic patients, Acta Virol. 31: 443–446.Google Scholar
  5. Brown, S. M., Shbak-Sharpe, J. H., Warren, K. G., Wroblewska, Z., and Koprowski, H., 1979, Detection by complementation of defective or uninducible herpes simplex type 1 virus genomes latent in human ganglia, Proc. Natl. Acad. Sci USA 76: 2364–2368.PubMedCrossRefGoogle Scholar
  6. Cabrera, C. V., Wohlenberg, C., Openshaw, H., Rey-Mendez, M., Puga, A., and Notkins, L., 1980, Herpes simplex virus DNA sequences in the CNS of latently infected mice, Nature 288: 288–290.PubMedCrossRefGoogle Scholar
  7. Cappel, R., and Sprecher, S., 1983, Are herpes simplex virus responsible for neuropsychiatric diseases? in: Research on the Viral Hypothesis of Mental Disorders (P. V. Morozov, ed.), Adv. Biol. Psychiatry 12: 168–173.Google Scholar
  8. Cappel, R., Gregoire, F., Thirty, L., and Sprecher, S., 1978, Antibody and cell mediated immunity to herpes simplex virus in psychotic depression, J. Clin. Psychiatry 39: 266–268.PubMedGoogle Scholar
  9. Deatly, A. M., Spisack, J. D., Lavi, E., O’Boyle, D. R., and Fraser, N. W, 1988, Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome, J. Virol. 62: 749–756.PubMedGoogle Scholar
  10. Fraser, N., Lawrence, N. C., Wroblewska, Z., Gilden, D. H., and Koprowski, H., 1981, Herpes simplex type 1 DNA in human brain tissue, Proc. Natl. Acad. Sci. USA 78: 6461–6465.PubMedCrossRefGoogle Scholar
  11. Gannacliffe, A., Saldanka, J. A., Itzhaki, R. F., and Sutton, R. N. P., 1985, Herpes simplex viral DNA in temporal lobe epilepsy, Lancet 1: 214–215.CrossRefGoogle Scholar
  12. Gotlieb-Stematsky, T., Zonis, J., Arlazoroff, A., Mozes, T., Sigal, M., and Szekely, A. G., 1981, Antibodies to Epstein-Barr virus, herpes simplex type 1, cytomegalovirus and measles virus in psychiatric patients, Arch. Virol. 67: 333–339.PubMedCrossRefGoogle Scholar
  13. Gotlieb-Stematsky, T., Floru, S., Becker, D., Kritchman, E., and Leventon-Kriss, S., 1987, Antibody and cell mediated immunity to herpes simplex and Epstein-Barr viruses in psychotic patients, in: Viruses, Immunity and Mental Disorders ( E. Kurstak, Z. J. Lipowski, and P. V. Morozov, eds.), Plenum Medical, New York, pp. 173–178.Google Scholar
  14. Halonen, P. E., Rimón, R., Arohonka, K., and Jantti, V., 1974, Antibody levels to herpes simplex type 1, measles and rubella viruses in psychiatric patients, Br. J. Psychiatry 125: 461–465.PubMedCrossRefGoogle Scholar
  15. Hsiung, G. D., 1982, Diagnostic Virology, 3rd ed., Yale University Press, New Haven, Conn.Google Scholar
  16. Jorgensen, S. O., Goldschmidt, V. V, and Vestergaard, B. F., 1982, Herpes simplex virus antibodies in child psychiatric patients and normal children, Acta Psychiatr. Scand. 66: 42–49.CrossRefGoogle Scholar
  17. Klein, R. J., 1982, The pathogenesis of acute, latent and recurrent herpes simplex virus infections, Arch. Virol. 72: 143–168.PubMedCrossRefGoogle Scholar
  18. Kúdelová, M., Rajdni, J., Pogady, J., and Ramka, M.,1988, Herpes simplex virus DNA in the brain of psychotic patients, Acta Virol. 32:455–460.Google Scholar
  19. Lewis, M. E., Brown, S. M., Warren, K. G., and Subak-Sharpe, J. H., 1984, Recovery of herpes simplex virus genetic information from human trigeminal ganglion cells following superinfection with herpes simplex type 2 temperature sensitive mutants, J. Gen. Virol. 65: 215–219.PubMedCrossRefGoogle Scholar
  20. Libikovâ, H., 1983, Schizophrenia and viruses: Principles of etiologic studies, in: Advances in Biological Psychiatry, Volume 12 ( P V. Morozov, ed.), Karger, Basel, pp. 20–51.Google Scholar
  21. Lycke, E., Norrby, E., and Roos, B. E., 1974, Serological study of mentally ill patients with particular reference to the prevalence of herpes simplex virus infections, Br. J. Psychiatry 124: 273–279.PubMedCrossRefGoogle Scholar
  22. Maniaris, T., Fritsch, E. E, and Sambrook, J., 1982, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., pp. 84–94.Google Scholar
  23. Pogddy, J., and Ntidvornfk, P., 1982, Psychosurgery: Critical survey of hitherto experience, Cs. Psychiatr. 78: 3–16 [in Slovak].Google Scholar
  24. Pokomf, A., Rawls, W, Adam, E., and Mefferd, R., 1973, Depression, psychopathy and herpes virus type 1 antibodies. Lack of relationship, Arch. Gen. Psychiatry 29: 820–822.CrossRefGoogle Scholar
  25. RajLSni, J., tiampor, F., Sabó, A., Líbikovâ, H., and Rosenbergovâ, M., 1977, Activation of latent herpesvirus hominis in explants: Influence of immune serum, Arch. Virol. 54: 55–69.Google Scholar
  26. Rajdani, J., Líbikov6, H., Smereková, J., Mucha, V., Kiidelová, M., Pogdy, J., Breier, §., and §kodi ek, I.,1987, Investigations on the possible role of viruses affecting the CNS in the etiology of schizophrenia and related mental disorders, in: Viruses, Immunity and Mental Disorders (E. Kurstak, Z. J. Lipowski, and R V. Morozov, eds.), Plenum Medical, New York, pp. 135–148.Google Scholar
  27. Rajdani, J., Herget, U., KoIt41, M., and Kaemer, H. C., 1990, Latency competence of herpes simplex virus strains ANG, ANGpath and its gC and gE minus mutants. Acta Virol. 34: 477–486.Google Scholar
  28. Rigby, P. W. J., Dickmann, M., Rhodes, C., and Berg, P., 1977, Labelling deoxyribonucleic acid to high specific activity by in vitro nick translation with DNA polymerase I, J. Mol. Biol. 113: 237–251.PubMedCrossRefGoogle Scholar
  29. Rimón, R., 1983, Viral aetiology of schizophrenia? Ann. Clin. Res. 15: 1–3.PubMedGoogle Scholar
  30. Rimón, R., and Halonen, P., 1969, Herpes simplex virus infection and depressive illness, Dis. New Syst. 30: 338–340.Google Scholar
  31. Rimón, R., Nishuri, M., and Halonen, P., 1978, Serum and CSF antibody levels to herpes simplex type 1, measles and rubella viruses in patients with schizophrenia, Ann. Clin. Res. 10: 291–293.PubMedGoogle Scholar
  32. Rimón, R., Halonen, P., Puhakka, P., Laitinen, L., Marttila, R., and Salmela, L., 1979, Immunoglobulin G antibodies to herpes simplex virus detected by radioimmunoassay in serum and cerebrospinal fluid of patients with schizophrenia, J. Clin. Psychiatry 64: 241–243.Google Scholar
  33. Rimón, R., Ahokas, A., and Palo, J., 1986, Serum and cerebrospinal fluid antibodies to cytomegalovirus in schizophrenia, Acta Psychiatr. Scand. 73: 642–644.PubMedCrossRefGoogle Scholar
  34. Sequeira, L. W, Jenninys, L. C., Carraseo, L. H., Lord, M. A., Curry, A., and Sutton, R. N. P., 1979, Detection of herpes simplex viral genome in brain tissue, Lancet 2: 609–612.CrossRefGoogle Scholar
  35. Stevens, J. G., 1975, Latent herpes simplex virus and the nervous system, Curr. Top. Microbiol. Immunol. 70: 31–50.PubMedCrossRefGoogle Scholar
  36. Stroop, W. G., 1986, Herpes simplex virus encephalitis of the adult: Reactivation of latent brain infection, Pathol. Immunopathol. Res. 5: 156–169.PubMedCrossRefGoogle Scholar
  37. Stroop, W. G., Rock, D. L., and Fraser, N. W., 1984, Localization of herpes simplex virus in the trigeminal and olfactory system of the mouse CNS during acute and latent infections by in situ hybridization, Lab. Invest. 51: 27–38.PubMedGoogle Scholar
  38. Thomas, E., Lycke, E., and Vahlne, A., 1985, Retrieval of latent herpes simplex type 1 genetic information from murine trigeminal ganglia by superinfection with heterotypic virus in vivo, J. Gen. Virol. 66: 1763–1770.PubMedCrossRefGoogle Scholar
  39. Torrey, E., Yolken, R., and Winfrey, C., 1982, Cytomegalovirus antibody in CSF of schizophrenic patients detected by enzyme immunoassay, Science 216: 892–894.PubMedCrossRefGoogle Scholar
  40. Torrey, E., Yolken, R. H., and Albrecht, P., 1983, Cytomegalovirus as a possible etiological agent in schizophrenia, in: Research on the Viral Hypothesis of Mental Disorders, Adv. Biol. Psychiatry 12: 150–160.Google Scholar
  41. Whitby, A. J., Blyth, W. A., and Hill, T. J., 1987, The effect of DNA hypomethylating agents on the reactivation of herpes simplex virus from latently infected mouse ganglia in vitro, Arch. Virol. 97: 137–144.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1991

Authors and Affiliations

  • J. Rajčáni
    • 1
  • M. Murányiová
    • 2
  • M. Kúdelová
    • 1
  • J. Pogády
    • 2
  • V. Mucha
    • 1
  • P. Babál
    • 3
  1. 1.Institute of VirologySlovak Academy of SciencesBratislavaCzechoslovakia
  2. 2.Mental Research LaboratoryInstitute of Medical BionicsBratislavaCzechoslovakia
  3. 3.Department of PathologyMedical FacultyBratislavaCzechoslovakia

Personalised recommendations